Zoetis Inc Intrinsic Stock Value – $100 Invested in Zoetis 10 Years Ago Now Worth Over xxx – Benzinga
December 22, 2023
☀️Trending News
Overall, Zoetis ($NYSE:ZTS) has been an incredible stock to own for the past 10 years. Its long-term growth and steady dividends have made it a great choice for investors seeking a reliable and consistent return on their investments. With a strong product portfolio and the potential for future growth, Zoetis looks well-positioned to continue delivering strong returns to its investors for the foreseeable future.
Price History
On Thursday, ZOETIS INC stock opened at $196.0 and closed at $194.7. This increase in value is largely attributed to the company’s success in the animal health industry, particularly its focus on providing innovative products and services to veterinarians, livestock producers and other animal health care providers. Furthermore, Zoetis has also been successful in creating a strong brand presence in the market, with a strong balance sheet and a robust pipeline of new products and services. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Zoetis Inc. More…
| Total Revenues | Net Income | Net Margin |
| 8.37k | 2.28k | 28.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Zoetis Inc. More…
| Operations | Investing | Financing |
| 2k | -883 | -904 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Zoetis Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 13.75k | 9.13k | 10.05 |
Key Ratios Snapshot
Some of the financial key ratios for Zoetis Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 8.6% | 10.6% | 37.3% |
| FCF Margin | ROE | ROA |
| 15.4% | 42.2% | 14.2% |
Analysis – Zoetis Inc Intrinsic Stock Value
At GoodWhale, we conducted an analysis of ZOETIS INC‘s wellbeing. Through our proprietary Valuation Line, we calculated that the intrinsic value of their share is around $192.1. We found that currently ZOETIS INC stock is being traded at $194.7, which is a fair price, although slightly overvalued by 1.3%. Our analysis has proved that ZOETIS INC is a healthy company and its stock is a worthwhile investment for investors. More…
Peers
Zoetis Inc. is a global animal health company that develops, manufactures, and markets a wide range of veterinary products. The company’s products include vaccines, parasiticides, pharmaceuticals, diagnostics, and biologics. Zoetis Inc. has a broad portfolio of products that are used in the prevention, treatment, and control of disease in animals. The company’s competitors include BioGaia AB, Krka d.d., and Phibro Animal Health Corp.
– BioGaia AB ($OTCPK:BIOGY)
Biogaia is a Swedish biotech company that markets probiotic products for infants, children, and adults. The company’s products are based on the lactic acid bacterium Lactobacillus reuteri, which is found naturally in the human gastrointestinal tract. Biogaia’s products are sold in over 60 countries worldwide.
Biogaia’s market cap is 800.05M as of 2022. The company has a Return on Equity of 10.86%. Biogaia’s products are based on the lactic acid bacterium Lactobacillus reuteri, which is found naturally in the human gastrointestinal tract. Biogaia’s products are sold in over 60 countries worldwide.
– Krka d.d. ($LTS:0HLK)
Krka d.d. is a Slovenian pharmaceutical company. It is the largest pharmaceutical company in Slovenia and one of the largest in the Balkans. The company was founded in 1959 and is headquartered in Novo mesto. Krka d.d. has a market cap of 2.77B as of 2022 and a Return on Equity of 12.85%. The company’s main products are prescription drugs, over-the-counter drugs, and medical devices.
– Phibro Animal Health Corp ($NASDAQ:PAHC)
Phibro Animal Health Corporation is a diversified animal health and specialty ingredients company with products in over 100 countries. The company’s products are sold through veterinarians, distributors, and feed stores. Phibro Animal Health Corporation’s mission is to improve the health and productivity of animals. The company’s products are used in a variety of animals, including cattle, swine, poultry, and aquaculture. Phibro Animal Health Corporation’s products are designed to improve the health and productivity of animals while providing a safe and healthy environment for them to live in.
Summary
Investing in Zoetis Inc. has proven to be a lucrative long-term bet. The firm has heavily invested in R&D and is focused on developing new products and services to meet evolving industry needs. In addition, Zoetis Inc. has a strong balance sheet that has enabled them to sustain profits and pay out dividends to shareholders. Overall, Zoetis Inc. is a reliable stock to add to any portfolio.
